CX3CL1/CX3CR1-Mediated Microglia Activation Plays a Detrimental Role in Ischemic Mice Brain via p38MAPK/PKC Pathway

Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling

(2014) Teresita L Briones et al.   Journal of Neuroinflammation

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke

(2014) Zhiwei Tang et al.   Journal of Neuroinflammation

The role of the microglia in acute CNS injury

(2014) Masahito Kawabori et al.   METABOLIC BRAIN DISEASE

Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway

(2014) Zhong-Ming Qian et al.   MOLECULAR NEUROBIOLOGY

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

(2014) Viktoria Gudi et al.   Frontiers in Cellular Neuroscience

Importance of glial activation in neuropathic pain

(2013) Joanna Mika et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice

(2013) Stefano Fumagalli et al.   GLIA

CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling

(2013) Dariusz Szukiewicz et al.   INFLAMMATION RESEARCH

Microglial Phenotype and Adaptation

(2013) B. J. L. Eggen et al.   Journal of Neuroimmune Pharmacology

COL-3, a Chemically Modified Tetracycline, Inhibits Lipopolysaccharide-Induced Microglia Activation and Cytokine Expression in the Brain

(2013) Rawan Abdulhameed Edan et al.   PLoS One

Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage

(2013) G. K. Sheridan et al.   Open Biology

Therapeutic potential of the chemokine–receptor duo fractalkine/CX3CR1: an update

(2012) Jan G D'Haese et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Adenosine A2A Receptor Deficiency Up-Regulates Cystatin F Expression in White Matter Lesions Induced by Chronic Cerebral Hypoperfusion

(2012) Wei Duan et al.   PLoS One

In vivo structure/function and expression analysis of the CX3C chemokine fractalkine

(2011) K.-W. Kim et al.   BLOOD

Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801

(2011) Xiao-mei Wu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase a pathway

(2011) Fang Du et al.   GLIA

CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents

(2011) R. Cipriani et al.   JOURNAL OF NEUROSCIENCE

Repertoire of microglial and macrophage responses after spinal cord injury

(2011) Samuel David et al.   NATURE REVIEWS NEUROSCIENCE

Characterization of Synergistic Induction of CX3CL1/Fractalkine by TNF-  and IFN-  in Vascular Endothelial Cells: An Essential Role for TNF-  in Post-Transcriptional Regulation of CX3CL1

(2010) T. Matsumiya et al.   JOURNAL OF IMMUNOLOGY

Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse

(2008) Ádám Dénes et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM